Skip to main content

Suggestions for an appropriate methodological approach for the validation of an evacuated blood collection tube made in plastic material including the effect of age.

Foucher K, Toulon P, Schved JF, Polack B

Publication: Thromb Haemost (2004) • Vol 91 • Page 845-7PMID: 15045160View on PubMed

Purpose

The purpose of this paper was to determine the effects of collection tube type and tube age on coagulation testing among specimens drawn from patients undergoing different types of anticoagulant treatment.

Conclusion

In general, the differences noted in routine coagulation tests due to collection of specimens in plastic versus glass tubes and due to the age of the plastic tubes (beginning or end of shelf life) were observed among the specimens collected from patients on anticoagulant therapy and not those collected from normal patients. However, factor VIII levels in specimens from non-anticoagulated patients with normal factor VIII levels were significantly higher in glass versus plastic tubes, with the end of shelf life plastic tubes giving measurements that were on average 8% lower than the glass tube results, and a smaller difference observed between glass and beginning of shelf life plastic tubes.

Studies (1)

Purpose

The purpose of this study was to determine the effects of collection tube type and tube age on coagulation testing among specimens drawn from patients undergoing different types of anticoagulant treatment.

Summary of Findings

There were no significant differences in fibrinogen, factor VIIa, factor XIIa, factor V, or factor VIII (deficient patients) results between specimens collected from non-anticoagulated patients in glass and plastic tubes, regardless of the age of the tube. The authors also state that PT and APTT were not significantly different between the tube types or tube ages in specimens collected from non-anticoagulated patients. On the other hand, factor VIII levels in specimens from non-anticoagulated patients with normal factor VIII levels were significantly higher glass tubes versus plastic tubes, with the end of shelf life plastic tubes giving measurements that were on average 8% lower than the glass tube results and the beginning of shelf life plastic tubes showing a smaller difference. For specimens from patients undergoing unfractionated heparin therapy, APTT was significantly longer in those specimens collected in glass tubes compared to either the beginning of the shelf life or the end of the shelf life plastic tubes, and APTT was significantly shorter among specimens collected in plastic tubes that were at the end of their shelf life than at the beginning. For specimens from patients on either unfractionated heparin therapy or low molecular weight heparin therapy, antiXa measurements were significantly higher in specimens collected in glass tubes than those collected in plastic tubes at the end of their shelf life.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Not specified
    Other diagnoses
  • Platforms

    MorphologyHematology/ auto analyzer
    GlycoproteinHematology/ auto analyzer
    ProteinHematology/ auto analyzer
    ProteinELISA
    ProteinEnzyme assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Factor VIII deficient
    PreaquisitionOther drugs
    Low molecular weight heparin therapy
    No anticoagulant treatment
    Oral anticoagulant therapy
    Unfractionated heparin therapy
    Biospecimen AcquisitionType of collection container/solution
    Plastic Vacutainer citrate Plus tubes (1 month to expiration)
    Plastic Vacutainer citrate Plus tubes (7 months to expiration)
    Siliconized glass Vacutainer tubes (7 months to expiration)